CEP250 抗体
Quick Overview for CEP250 抗体 (ABIN5699876)
抗原
See all CEP250 抗体适用
宿主
克隆类型
标记
应用范围
- 
    - 
                                            免疫原
- centrosomal protein 250kDa
- 
                                            亚型
- IgG
 
- 
                                            
- 
    
- 
    - 
                                            应用备注
- WB : 1:200-1:2000 IP : 1:200-1:2000 IHC : 1:50-1:500 IF : 1:50-1:500
- 
                                            说明
- 
                        HeLa cells were subjected to SDS PAGE followed by western blot with FNab01601(CEP250,C-NAP1 antibody) at dilution of 1:500 
- 
                                            限制
- 仅限研究用
 
- 
                                            
- 
    - 
                                            缓冲液
- PBS with 0.02 % sodium azide and 50 % glycerol pH 7.3
- 
                                            储存液
- Sodium azide
- 
                                            注意事项
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- 
                                            注意事项
- Avoid repeated freeze / thaw cycles.
- 
                                            储存条件
- -20 °C
- 
                                            有效期
- 12 months
 
- 
                                            
- 
    - CEP250 (Centrosomal Protein 250kDa (CEP250))
- 
                                            别名
- CEP250
- 
                                            背景
- Synonyms:250 kDa centrosomal protein, C NAP1, Centrosomal protein 2, centrosomal protein 250 kDa, CEP2, CEP250, CNAP1, C-NAP1 Background:Probably plays an important role in centrosome cohesion during interphase.
- 
                                            基因ID
- 11190
- 
                                            UniProt
- Q9BV73
- 
                                            途径
- M Phase, SARS-CoV-2 Protein Interactome
 抗原
- 
                    
 
                                     
                                     
                                    